This research focuses on the role of ADAM10, a protease involved in synaptic function, in neuronal plasticity and Alzheimer’s disease. Endocytosis of ADAM10 regulates its activity and influences synaptic remodeling, a process impaired in Alzheimer’s.
The study suggests that dysregulated ADAM10 trafficking contributes to amyloid pathology and cognitive decline. Restoring proper ADAM10 function could mitigate synaptic deficits and neuronal loss.
These findings highlight ADAM10 as a potential therapeutic target for preserving cognitive function in Alzheimer’s patients.
